Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 23684627)

1.

Role of complement in host-microbe homeostasis of the periodontium.

Hajishengallis G, Abe T, Maekawa T, Hajishengallis E, Lambris JD.

Semin Immunol. 2013 Feb;25(1):65-72. doi: 10.1016/j.smim.2013.04.004. Epub 2013 May 16. Review.

2.

Complement and periodontitis.

Hajishengallis G.

Biochem Pharmacol. 2010 Dec 15;80(12):1992-2001. doi: 10.1016/j.bcp.2010.06.017. Epub 2010 Jun 23. Review.

3.

Complement and dysbiosis in periodontal disease.

Hajishengallis G, Lambris JD.

Immunobiology. 2012 Nov;217(11):1111-6. doi: 10.1016/j.imbio.2012.07.007. Review.

4.

Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement.

Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, McIntosh ML, Alsam A, Kirkwood KL, Lambris JD, Darveau RP, Curtis MA.

Cell Host Microbe. 2011 Nov 17;10(5):497-506. doi: 10.1016/j.chom.2011.10.006. Epub 2011 Oct 27.

5.

Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonist.

Abe T, Hosur KB, Hajishengallis E, Reis ES, Ricklin D, Lambris JD, Hajishengallis G.

J Immunol. 2012 Dec 1;189(11):5442-8. doi: 10.4049/jimmunol.1202339. Epub 2012 Oct 22.

6.

The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss.

Liang S, Krauss JL, Domon H, McIntosh ML, Hosur KB, Qu H, Li F, Tzekou A, Lambris JD, Hajishengallis G.

J Immunol. 2011 Jan 15;186(2):869-77. doi: 10.4049/jimmunol.1003252. Epub 2010 Dec 13.

7.

Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis.

Maekawa T, Abe T, Hajishengallis E, Hosur KB, DeAngelis RA, Ricklin D, Lambris JD, Hajishengallis G.

J Immunol. 2014 Jun 15;192(12):6020-7. doi: 10.4049/jimmunol.1400569. Epub 2014 May 7.

8.

Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response.

Hajishengallis G.

Trends Immunol. 2014 Jan;35(1):3-11. doi: 10.1016/j.it.2013.09.001. Epub 2013 Oct 23. Review.

9.

Breaking bad: manipulation of the host response by Porphyromonas gingivalis.

Hajishengallis G, Lamont RJ.

Eur J Immunol. 2014 Feb;44(2):328-38. doi: 10.1002/eji.201344202. Review.

10.

Periodontitis: a polymicrobial disruption of host homeostasis.

Darveau RP.

Nat Rev Microbiol. 2010 Jul;8(7):481-90. doi: 10.1038/nrmicro2337. Review.

PMID:
20514045
11.

TLR2 promoter hypermethylation creates innate immune dysbiosis.

Benakanakere M, Abdolhosseini M, Hosur K, Finoti LS, Kinane DF.

J Dent Res. 2015 Jan;94(1):183-91. doi: 10.1177/0022034514557545. Epub 2014 Nov 11.

PMID:
25389002
12.

Complement modulates the cutaneous microbiome and inflammatory milieu.

Chehoud C, Rafail S, Tyldsley AS, Seykora JT, Lambris JD, Grice EA.

Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):15061-6. doi: 10.1073/pnas.1307855110. Epub 2013 Aug 26.

13.

Drosophila as a model for intestinal dysbiosis and chronic inflammatory diseases.

Lee KA, Lee WJ.

Dev Comp Immunol. 2014 Jan;42(1):102-10. doi: 10.1016/j.dci.2013.05.005. Epub 2013 May 16. Review.

PMID:
23685204
14.

Immune evasion strategies of Porphyromonas gingivalis.

Hajishengallis G.

J Oral Biosci. 2011;53(3):233-240.

15.

Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor.

Jagels MA, Ember JA, Travis J, Potempa J, Pike R, Hugli TE.

Adv Exp Med Biol. 1996;389:155-64.

PMID:
8861006
16.

Restoring host-microbe homeostasis via selective chemoattraction of Tregs.

Garlet GP, Sfeir CS, Little SR.

J Dent Res. 2014 Sep;93(9):834-9. doi: 10.1177/0022034514544300. Epub 2014 Jul 23. Review.

PMID:
25056995
17.

Diacerein: a potential therapeutic drug for periodontal disease.

Huang RY, Lu SH, Su KW, Chen JK, Fang WH, Liao WN, Chen SY, Shieh YS.

Med Hypotheses. 2012 Aug;79(2):165-7. doi: 10.1016/j.mehy.2012.04.024. Epub 2012 May 13.

PMID:
22583561
18.

Bis-enoxacin blocks rat alveolar bone resorption from experimental periodontitis.

Rivera MF, Chukkapalli SS, Velsko IM, Lee JY, Bhattacharyya I, Dolce C, Toro EJ, Holliday LS, Kesavalu L.

PLoS One. 2014 Mar 17;9(3):e92119. doi: 10.1371/journal.pone.0092119. eCollection 2014.

19.

Oral treatment with complement factor C5a receptor (CD88) antagonists inhibits experimental periodontitis in rats.

Breivik T, Gundersen Y, Gjermo P, Taylor SM, Woodruff TM, Opstad PK.

J Periodontal Res. 2011 Dec;46(6):643-7. doi: 10.1111/j.1600-0765.2011.01383.x. Epub 2011 Jul 3.

PMID:
21722134
20.

Defining dysbiosis and its influence on host immunity and disease.

Petersen C, Round JL.

Cell Microbiol. 2014 Jul;16(7):1024-33. doi: 10.1111/cmi.12308. Epub 2014 Jun 2. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk